International Clinical Trial: A randomised controlled trial to find out whether people with takotsubo cardiomyopathy should be prescribed a drug commonly used to relax blood vessels (renin angiotensin system inhibitors)

Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ISRCTN18302602) titled 'A randomised controlled trial to find out whether people with takotsubo cardiomyopathy should be prescribed a drug commonly used to relax blood vessels (renin angiotensin system inhibitors)' on July 1.

Study Type: Interventional

Study Design: Randomized controlled open-label parallel group study (Treatment)

Primary Sponsor: University of Aberdeen

Condition: Takotsubo cardiomyopathy Circulatory System

Intervention: An online tool will randomly assign participants in the EVEREST Trial to either receive RAS inhibition (oral angiotensin-converting enzyme inhibitor (ACEi) or oral angiotensin II receptor blocker...